PINK:ACNNF
AusCann Group Holdings Ltd Stock Company Profile
$0.0050
+0 (+0%)
At Close: Jun 14, 2024
Information
35 Havelock Street, Level 5
West Perth WA 6005
61 8 6305 0705
auscann.com.au
Industry: Drug Manufacturers—Specialty & Generic
Sector: Healthcare
Description
AusCann Group Holdings Ltd researches, develops, and commercializes various cannabinoid-derived therapeutic products for humans and animals in Australia and internationally. It offers tetrahydrocannabinol and cannabidiol powder-based hard-shell capsules using Neuvis technology platform for the treatment of pain and related indications; CPAT-01, a liquid, oral veterinary medicine to treat pain and inflammation in dogs; and DermaCann, a liquid oral oil formulation containing CBD for healthy skin and immune function in dogs. The company is headquartered in West Perth, Australia.
